CUBT logo for press releases.jpg
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
31 mars 2024 19h00 HE | Curative Biotechnology, Inc. 
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company...
180_CC_horizontal_logo.png
180 Degree Capital Corp. Notes Support of Its Board Nominee, Matthew F. Mclaughlin, by Board of Directors of comScore, Inc.
26 mars 2024 09h00 HE | 180 Degree Capital Corp.
MONTCLAIR, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ: TURN) (“180 Degree Capital”) today noted the announcement by comScore, Inc. (“SCOR”) that SCOR’s Nominating...
Sidetrade renforce s
Sidetrade renforce son agilité avec la nomination d'une Cheffe de cabinet
07 mars 2024 05h47 HE | Sidetrade
Sidetrade, plateforme d’intelligence artificielle (IA) dédiée à la sécurisation et à la génération du cashflow des entreprises, annonce la nomination de Carole Benichou en tant que Cheffe de cabinet,...
SIDETRADE_LOGO_2019_MASTER_WEB.JPG
Sidetrade strengthens scalability with Chief of Staff appointment
07 mars 2024 05h47 HE | Sidetrade
Sidetrade, the global leader in AI-powered Order-to-Cash applications, announces the appointment of Carole Benichou as its new Chief of Staff and latest addition to the executive committee. This...
180_CC_horizontal_logo.png
180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Second Month of Initial Measurement Period of its Discount Management Program
01 mars 2024 09h00 HE | 180 Degree Capital Corp.
MONTCLAIR, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (“180 Degree Capital”) (NASDAQ: TURN), noted today that the average discount between its estimated daily net asset value...
Osisko nomme David S
Osisko nomme David Smith à son conseil d'administration
24 janv. 2024 08h00 HE | Redevances Aurifères Osisko Ltée
MONTRÉAL, 24 janv. 2024 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) a le plaisir d'annoncer la nomination de M. David Smith à son...
20180109-ogr_200.jpg
Osisko Appoints David Smith to Its Board of Directors
24 janv. 2024 08h00 HE | Osisko Gold Royalties Ltd.
MONTRÉAL, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. David Smith to its Board...
logo TRANSGENE.jpg
Transgene annonce la nomination de James Wentworth comme Directeur du Business Development
22 janv. 2024 11h45 HE | Transgene S.A.
Strasbourg, France – Le 22 janvier 2023, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le cancer reposant sur des vecteurs...
logo_TRANSGENE.jpg
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer
22 janv. 2024 11h45 HE | Transgene S.A.
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased...
Image1.png
Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
04 janv. 2024 10h25 HE | EVEXTA BIO
Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer Paul Gineste brings 25 years of experience in clinical development and strategy with leading international...